Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Current Opinion in Lipidology
|
January 7, 2017
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
Amy C Burke, Murray W Huff
Current Opinion in Lipidology
|
January 26, 2018
Regression of atherosclerosis: lessons learned from genetically modified mouse models
Amy C Burke, Murray W Huff
Cardiovascular & Hematological Disorders Drug Targets
|
October 4, 2012
Citrus flavonoids and the prevention of atherosclerosis
Erin E Mulvihill, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 16, 2006
NPC1L1: evolution from pharmacological target to physiological sterol transporter
Murray W Huff, Rebecca L Pollex, Robert A Hegele
Circulation Research
|
August 30, 2014
Gene therapy for hypercholesterolemia: sweet dreams and flying machines
Murray W Huff, Julia M Assini, Robert A Hegele
Current Opinion in Lipidology
|
December 27, 2018
Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis
Amy C Burke, Dawn E Telford, Murray W Huff
Annual Review of Nutrition
|
May 6, 2016
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Erin E Mulvihill, Amy C Burke, Murray W Huff
Current Opinion in Lipidology
|
December 21, 2012
Citrus flavonoids and lipid metabolism
Julia M Assini, Erin E Mulvihill, Murray W Huff
Diabetes
|
September 30, 2003
Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation
Nica M Borradaile, Linda E de Dreu, Murray W Huff
Diabetes
|
May 28, 2005
Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes
Emma M Allister, Nica M Borradaile, Jane Y Edwards, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Current Opinion in Lipidology
|
January 7, 2017
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
Amy C Burke, Murray W Huff
Current Opinion in Lipidology
|
January 26, 2018
Regression of atherosclerosis: lessons learned from genetically modified mouse models
Amy C Burke, Murray W Huff
Cardiovascular & Hematological Disorders Drug Targets
|
October 4, 2012
Citrus flavonoids and the prevention of atherosclerosis
Erin E Mulvihill, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 16, 2006
NPC1L1: evolution from pharmacological target to physiological sterol transporter
Murray W Huff, Rebecca L Pollex, Robert A Hegele
Circulation Research
|
August 30, 2014
Gene therapy for hypercholesterolemia: sweet dreams and flying machines
Murray W Huff, Julia M Assini, Robert A Hegele
Current Opinion in Lipidology
|
December 27, 2018
Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis
Amy C Burke, Dawn E Telford, Murray W Huff
Annual Review of Nutrition
|
May 6, 2016
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Erin E Mulvihill, Amy C Burke, Murray W Huff
Current Opinion in Lipidology
|
December 21, 2012
Citrus flavonoids and lipid metabolism
Julia M Assini, Erin E Mulvihill, Murray W Huff
Diabetes
|
September 30, 2003
Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation
Nica M Borradaile, Linda E de Dreu, Murray W Huff
Diabetes
|
May 28, 2005
Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes
Emma M Allister, Nica M Borradaile, Jane Y Edwards, et al.
Page
of 8